Autoimmunity and Inflammation Link to Cardiovascular Disease Risk in Rheumatoid Arthritis
Emerging studies aim to better understand therapeutic interventions that may mitigate increased CVD risk in patients with RA.
All articles by Jasenka Piljac, PhD
Interleukin-6: Pathophysiology and Clinical Implications in Rheumatoid Arthritis
The realization that IL-6 is implicated in many pathologic features of RA has prompted the search for IL-6-blocking agents as therapeutic options for this condition.
Next post in Rheumatoid Arthritis
